Dear Participants We cordially invite you to the 10th KoNECT-MOHW-MFDS International Conference (2024 KIC)

On behalf of the Organizing Committee as well as the Program Committee, we are pleased to invite you to the 2024 KIC, co-hosted by Ministry of Health and Welfare and Ministry of Food and Drug Safety.

KIC has been holding the International Convention every year for invigorating and growing the Korea Clinical Trials and Operations. It has already been 10 years since KIC was held. This year also, we are pleased to announce the 10th KIC will be held on October 29-31, 2024 at Dragon City, Seoul.
Through various programs of KIC 2024 including Recruitment Information Session, Exhibition, and Conference, exchange the newest clinical trials and bio technology as well as get the business opportunity with various international academics, professionals, and CEOs of the global clinical trials and bio-tech of healthcare field. At this KIC, 'Integrating Past, Present and Future: Advancing Pharmaceutical Development through Innovation’ makes you gain innovative by covering a variety of topics in new drug development.

Our unparalleled conference on clinical trials and new drug development in Asia ensures exceptional lecture and presentation quality. Over the three-day program, attendees will gain insights into current trends and future considerations in Korean clinical trials.

The comprehensive agenda includes lectures, talk shows, and sessions on innovative drug development technologies. Topics cover new drug development cases, FDA IND regulatory updates, emerging therapeutics, and data-driven methodologies. Sessions on regenerative medicine, bio-pharmaceuticals, and AI-driven drug development will delve into medical and clinical trial advancements. Specific topics such as oncology, obesity, and Alzheimer's disease will also be explored, alongside practical considerations for operations and quality control in clinical trials.

We extend our heartfelt gratitude to the Conference Program Committee for their invaluable contributions. We also sincerely thank MOHW and MFDS for their dedicated support of public health and clinical trials in Korea.
With genuine sincerity, we hope that your experience at the 2024 KIC will be truly meaningful and rewarding, and that all participants will derive immense satisfaction and enjoyment from their participation in the 10th KoNECT International Conference.